Wall Street Breakfast Podcast: Merck Talks, Cidara Soaring

Group 1: Merck and Cidara Therapeutics Acquisition - Merck is nearing an acquisition of Cidara Therapeutics, potentially valuing the deal above $3.3 billion, with Cidara's stock up 85% following the news [3][4] - Cidara is recognized for its long-acting antibody medicine that protects against flu, and the deal could be announced as soon as Friday [4] - The acquisition is expected to involve cash upfront and additional payouts tied to future clinical trial milestones [5] Group 2: U.S.-Argentina Trade Agreement - The U.S. plans to lift tariffs on certain foods and imports from Argentina, Ecuador, Guatemala, and El Salvador to expand market access for U.S. companies [5] - Argentina will provide preferential access for various U.S. exports, including medicines, chemicals, and agricultural goods [6] - Ecuador will lower or eliminate tariff barriers on key products, including tree nuts and fresh fruit, and remove a variable tariff on many agricultural products [6] Group 3: DoorDash Cybersecurity Incident - DoorDash reported a cybersecurity breach involving unauthorized access to user information, but there is no indication of data misuse for fraud or identity theft [7][8] - The company is enhancing its security measures, increasing employee training, and collaborating with an outside firm for investigation [8] - This incident follows a previous breach in 2019, where information from about 5 million customers and merchants was exposed [8]